Literature DB >> 14734753

Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Marco A Campos1, Meire Closel, Eneida P Valente, Jarbas E Cardoso, Shizuo Akira, Jacqueline I Alvarez-Leite, Catherine Ropert, Ricardo T Gazzinelli.   

Abstract

Studies performed in vitro suggest that activation of Toll-like receptors (TLRs) by parasite-derived molecules may initiate inflammatory responses and host innate defense mechanisms against Trypanosoma cruzi. Here, we evaluated the impact of TLR2 and myeloid differentiation factor 88 (MyD88) deficiencies in host resistance to infection with T. cruzi. Our results show that macrophages derived from TLR2 (-/-) and MyD88(-/-) mice are less responsive to GPI-mucin derived from T. cruzi trypomastigotes and parasites. In contrast, the same cells from TLR2(-/-) still produce TNF-alpha, IL-12, and reactive nitrogen intermediates (RNI) upon exposure to live T. cruzi trypomastigotes. Consistently, we show that TLR2(-/-) mice mount a robust proinflammatory cytokine response as well as RNI production during the acute phase of infection with T. cruzi parasites. Further, deletion of the functional TLR2 gene had no major impact on parasitemia nor on mortality. In contrast, the MyD88(-/-) mice had a diminished cytokine response and RNI production upon acute infection with T. cruzi. More importantly, we show that MyD88(-/-) mice are more susceptible to infection with T. cruzi as indicated by the higher parasitemia and accelerated mortality, as compared with the wild-type mice. Together, our results indicate that T. cruzi parasites elicit an alternative inflammatory pathway independent of TLR2. This pathway is partially dependent on MyD88 and necessary for mounting optimal inflammatory and RNI responses that control T. cruzi replication during the early stages of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734753     DOI: 10.4049/jimmunol.172.3.1711

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.

Authors:  Malcolm S Duthie; Maria Kahn; Maria White; Raj P Kapur; Stuart J Kahn
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.

Authors:  Braulia C Caetano; Bianca B Carmo; Mariane B Melo; Anna Cerny; Sara L dos Santos; Daniella C Bartholomeu; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

3.  MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.

Authors:  K A Rogers; A B Rogers; B A Leav; A Sanchez; E Vannier; S Uematsu; S Akira; D Golenbock; H D Ward
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  NLR proteins and parasitic disease.

Authors:  Gwendolyn M Clay; Fayyaz S Sutterwala; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.

Authors:  Ana-Carolina Oliveira; Bruna C de Alencar; Fanny Tzelepis; Weberton Klezewsky; Raquel N da Silva; Fabieni S Neves; Gisele S Cavalcanti; Silvia Boscardin; Marise P Nunes; Marcelo F Santiago; Alberto Nóbrega; Maurício M Rodrigues; Maria Bellio
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

6.  IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.

Authors:  Paulo Marcos da Matta Guedes; Fredy R S Gutierrez; Flavia L Maia; Cristiane M Milanezi; Grace K Silva; Wander R Pavanelli; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16

7.  UNC93B1 mediates host resistance to infection with Toxoplasma gondii.

Authors:  Mariane B Melo; Pia Kasperkovitz; Anna Cerny; Stephanie Könen-Waisman; Evelyn A Kurt-Jones; Egil Lien; Bruce Beutler; Jonathan C Howard; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

8.  The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein.

Authors:  Ricardo Silvestre; Ana M Silva; Anabela Cordeiro-da-Silva; Ali Ouaissi
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

9.  Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells.

Authors:  Sungsook Yu; Hyun Hwa Cho; Hye Joon Joo; Yong Chan Bae; Jin Sup Jung
Journal:  Mol Cell Biochem       Date:  2008-06-26       Impact factor: 3.396

10.  NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

Authors:  Hisako Kayama; Ritsuko Koga; Koji Atarashi; Megumi Okuyama; Taishi Kimura; Tak W Mak; Satoshi Uematsu; Shizuo Akira; Hiroshi Takayanagi; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.